Astellas Pharma | 4503 - Operating Profit

Stock Price
2,150.50
Daily Change
6.50 0.30%
Monthly
0.96%
Yearly
46.14%
Q1 Forecast
2,057.60

Astellas Pharma reported JPY104.41B in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Astellas Pharma JPY 104.41B 11.87B Sep/2025
Chugai Pharma JPY 169.01B 12.52B Dec/2025
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Eisai JPY 13.67B 7.07B Sep/2025
Kyowa Hakko Kirin JPY 25.86B 13.04B Sep/2025
M3 JPY 15.68B 3.06B Sep/2025
Otsuka Holdings JPY 168.82B 61.81B Sep/2025
Shionogi JPY 73.97B 34.3B Dec/2025
Sumitomo Dainippon JPY 75.66B 54.63B Sep/2025
Takeda JPY 168.82B 479.89B Dec/2025
Terumo JPY 45.1B 10.79B Sep/2025